Top Markets
#1 Black Phoenix Black Phoenix +367.29%
#2 Islamic Coin Islamic Coin +158.24%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +55.02%
#5 Akedo Akedo +53.30%
#6 Acurast Acurast +37.40%
#7 BasedHype BasedHype +30.34%
#8 Cryptopia Cryptopia +22.42%
#9 Avantis Avantis +21.94%
#10 Playnance Playnance +19.70%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Destiny Pharma plc Destiny Pharma plc

Destiny Pharma plc

DEST
Rank in Stocks #41146
Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in... Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in 1996, specializing in the identification, progression, and market introduction of pharmaceutical solutions for infectious diseases. The company's clinical pipeline includes NTCD-M3, currently in Phase III trials to prevent recurring Clostridioides difficile infections. Its XF-73 program features XF-73 Nasal, undergoing Phase II development for the prevention of post-surgical staphylococcal infections, and XF-73 Dermal, which is in Phase I for treating bacterial skin infections resistant to antibiotics. Additionally, Destiny Pharma's preclinical efforts involve SPOR-COV, a biotherapeutic product aimed at preventing COVID-19 and other viral respiratory diseases, and XF Drugs Biofilm, targeting antibiotic-resistant biofilm and bacterial aggregate infections. The company is also investigating further applications of its XF drugs for respiratory, oral mucosa, and ocular infections. Destiny Pharma maintains strategic alliances with various organizations, including China Medical System Holdings Limited, SporeGen Limited, the University of Southampton, Aston University, the University of Sheffield, Cardiff University, and Tianjin Medical University.
Share Price
$0.04082105
Last synced: 2024-08-12
Market Cap
$39.09K
Change (1 day)
-19.83%
Change (1 year)
0.00%
Country
GB
Trade Destiny Pharma plc (DEST)

Category

Healthcare
Number of shares outstanding for Destiny Pharma plc (DEST)
Number of shares outstanding as of December 2023: 95.27M
According to Destiny Pharma plc latest financial reports and stock price the company's current number of shares outstanding is 95.27M. At the end of December 2022 the company had 70.20M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Destiny Pharma plc (DEST) from 2013 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 95.27M 5.07%
2023 90.67M 29.16%
2022 70.20M 17.26%
2021 59.87M 32.36%
2020 45.23M 2.84%
2019 43.98M 0.54%
2018 43.74M 23.57%
2017 35.40M -15.36%
2016 41.82M 2.75%
2015 40.71M -2.68%
2014 41.82M 48.59%
2013 28.15M 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 166.51%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -34.73%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE